Comment by Dr. Mark Freedman
NeuroSens survey on sequencing – Part 1

Over a dozen disease-modifying therapies (DMT) are now available to treat relapsing forms of multiple sclerosis (MS), providing clinicians with a wealth of choices for initiating and maintaining therapy. But what is the rational approach to selecting the most appropriate therapy in an individual patient throughout the treatment course? Read More